Status:
COMPLETED
Examining Persistence in Smokers With Schizophrenia
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Cessation
Schizophrenia
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
All participants will receive free weekly counseling (8- weeks) and free nicotine patches (10-weeks). They will complete assessment measures commonly used in smoking cessation studies. We hope to show...
Detailed Description
This study is a non-randomized trial of a new psychosocial treatment for smoking cessation (for smokers with schizophrenia) that is based on cognitive behavioral therapy for smoking cessation - a comm...
Eligibility Criteria
Inclusion
- Must be between 18 - 64 years old
- Must indicate commitment to quitting smoking in the next 30 days
- Must smoke at least 5 cigarettes per day for past 6-months
- Expired breath carbon monoxide (CO) \> 5 to ensure daily cigarette use
- Must score \< 8 (or \<7 for women) on the Alcohol Use Disorders Identification Test
- Must score less than 3 on the 6-month Drug Abuse Screening Test-10
- Must provide a negative urine drug screen for cannabis, cocaine, opiates, or
- methamphetamine (Note: Participants with a positive screen for opiates may
- participate with proof of prescription for opiates.)
- Must have a diagnosis of Schizophrenia or Schizoaffective Disorder on Structured Clinical Interview
- Psychiatric illness must be stable, as indicated by no hospitalizations in previous 8 weeks, and a stable psychotropic medication regimen including a stable antipsychotic dose for 8 weeks
Exclusion
- Must not be currently receiving tobacco dependence treatment counseling
- Must not currently be taking varenicline (Chantix)
- Must not be taking bupropion (Zyban/Wellbutrin) to quit smoking
- Must not be taking any nicotine preparations (gum, lozenge, patch, spray, inhaler) daily over the last 10 days.
- Must not report unstable angina pectoris, myocardial infarction, or significant cardiac arrhythmia (including atrial fibrillation) in the past 90 days
- Must not be pregnant, breastfeeding, or planning on becoming pregnant in the next 4-months. Women who can become pregnant may be included if using effective birth control
- Must not have pending legal matters with potential to result in jail time
- Must not be planning on moving outside local area in next 3-months
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 13 2018
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT03346291
Start Date
January 1 2017
End Date
June 13 2018
Last Update
January 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901